COVID-19 vaccine improves outlook, yet gold remains relevant
Sponsored Content from World Gold Council
The gold price reached record highs in 2020, a year that will be remembered for its unpredictability. With US election results now confirmed and positive news of a COVID-19 vaccine, how has gold been affected and what does the future hold?
Markets regained a sense of status quo after the result of the US election and assurance that Joe Biden will take the Presidency in January. News of vaccines that work effectively against COVID-19 has also propelled this sentiment: driving demand for risky assets while demand for gold levelled off.
Some of gold’s recent price movements, while large, were not unprecedented. Gold has seen approximately 16 single-day price drops of more than 4% over the last 15 years, the most recent this past August. In a particular case this November, gold’s pullback was primarily driven by positive market sentiment (risk reduction) following Pfizer’s announcement and aided by investor positioning (momentum).
The key question facing gold investors now is whether this the start of trend reversal, a temporary move, or perhaps an opportunity to buy.
To understand gold’s performance, it is important to consider its four key drivers:
- Economic expansion: periods of growth are very supportive of jewellery, technology and long-term savings
- Risk and uncertainty: market downturns often boost investment demand for gold as a safe haven
- Opportunity cost: interest rates and relative currency strength influence investor attitudes towards gold
- Momentum: capital flows, positioning and price trends can ignite or dampen gold's performance.
Gold has regained some ground since it’s drop in November and early December, and while price volatility may persist in the short term, we believe this could be seen as a buying opportunity for many strategic investors. The reasons are three-fold:
Consumer demand may start to see signs of recovery. The price correction and slightly more positive economic outlook may revitalise gold’s consumer demand, removing – at least in part – one of the significant headwinds it has faced this year. Historically, Indian and Chinese consumers have often used price dips to buy gold. And we have seen similar behaviour among more strategic Western investors.
Investment demand is not likely going away. While news about the vaccine is definitely positive and rightfully fuelling optimism, there are still challenges ahead. These include further approvals and distribution logistics which may delay its rollout around the globe, thus maintaining a level of uncertainty over the coming months. And some significant risks that existed prior to the COVID-19 pandemic remain as contributors to heightened global uncertainty (for example, Brexit, political gridlock in the US, trade tensions, etc). But perhaps more importantly, the pandemic has already had a significant negative impact on the global economy that will take time – and a lot of stimuli from governments – to overcome.
Loose monetary policy will reshape asset allocation. In addition to the fiscal largesse, interest rates are set to remain very low for a long time. As we discussed in our mid-year outlook, this may not only result in high inflation but is likely to re-shape asset allocation strategies for years to come. Amid such an environment, gold could play an increasingly relevant role as a diversifier and source of returns.
Where do we go from here?
For many of us, this year has been overshadowed by COVID-19 and the US election. Looking ahead to 2021, there are questions over whether the record gold interest we saw in these unprecedented times will fade.
However, we don’t think so. There has been a noticeable shift in how investors see and use gold over the last few years, and with recent debate over the effectiveness of traditional asset allocation models, gold will likely retain its relevance.
Learn more about gold’s role as a strategic investment on Goldhub.
This content was provided by World Gold Council. Kiplinger is not affiliated with and does not endorse the company or products mentioned above.
4 Big Retirement Blunders (and How to Avoid Them)
The 25 Cheapest U.S. Cities to Live In
The Best Vanguard Funds for 401(k) Retirement Savers
13 States That Tax Social Security Benefits